Please login to the form below

Artificial Intelligence: the new healthcare algorithm

The age of computers has hugely evolved, and with the emergence of effective machine learning, pattern recognition, and decision-making algorithms, Artificial Intelligence provides a revolutionary new approach to tailored healthcare. Associate Medical Copywriter Kulveer Singh dives deeper into the technology.
Artificial Intelligence (AI) is the science and engineering of making intelligent machines, and the art of using computers to understand human intelligence. When it comes to healthcare, AI can bring about radical changes to the way doctors and physicians access, communicate, and interact with patient data. Crucially, this can result in improved patient outcomes and even the possibility of using an individual patient’s history - such as previous illnesses, allergies or even genetic makeup - to predict their exact treatment requirements.

Associate Medical Copywriter Kulveer Singh explains how the introduction of AI can change the landscape of healthcare, why it’s an exciting time for the development of new technologies, and the challenges that implementing new AI may pose.

Better than humans? There’s proof!

In 2011, IBM’s supercomputer WATSON competed against and obliterated a long-term game show champion. All this, despite the general thought that computer programmes were unable to understand natural language, puns, red herrings, and to simply unpack the meaning behind game show questions.

With its ability to use natural language capabilities, hypothesis generation, and evidence-based learning, IBM WATSON has made the switch to healthcare and can support physicians in key decision-making processes. For example, an oncologist can use WATSON to assist in diagnosing and treating cancer patients. First, they might pose a query to the system, describing symptoms and other related factors (e.g. a patient has been suffering from severe and unexplained tiredness). WATSON begins by identifying the key pieces of information before mining through patient-related data to find relevant facts about family history, current medications, and other existing conditions. It combines this information with current findings from oncology clinical tests, doctors’ notes, treatment guidelines, instrument data, and scientific literature. It then examines these sources before forming hypotheses and testing them. WATSON will then provide a list of possible diagnoses with an accompanying score that indicates the level of confidence for each hypothesis. This contextual analysis allows WATSON to address complex problems, helping the doctor make more informed and accurate decisions.


Even Google with their DeepMind Health AI technology, have entered into the first NHS research project investigating how machine learning can help analyse ophthalmic scans, leading to earlier detection and intervention for patients with macular deterioration.
 


Download the full article from Blue Latitude Health

27th September 2016

Share

Tags

Company Details

Blue Latitude Health

+44 203 328 1840

Contact Website

Address:
Blue Latitude Health (UK)
140 Aldersgate Street
London
EC1A 4HY
United Kingdom

Latest content on this profile

In the precision medicine era, the line between products and services is blurred
Precision and personalised medicines are more than products, they are services in their own right. So, how should pharma approach this uncharted territory to ensure targeted therapies work for patients?
Blue Latitude Health
Understanding COVID-19 and varying responses across the globe
At the beginning of the COVID-19 Pandemic, Senior Account Executive Lauren Fernandes took a course at the London School of Hygiene and Tropical Medicine to better understand how the global response to the virus and to ensure we were best positioned to serve our clients during this challenging time. She shares the key learnings and why understanding the epidemiology of the disease is integral for fighting it.
Blue Latitude Health
Top 5 tips for a multi-indication product launch
Senior Associate Consultant Sana Rahim and Senior Consultant Victoria Clark explain the lessons the team has learned from launching six different indications of an oncology product in an accelerated timeframe.
Blue Latitude Health
If our patients are diverse, why are clinical trials so white?
Despite facing worse health outcomes, minority populations are often left out of clinical trials and miss the opportunity to participate in life-saving research. Associate Consultant Ling Song explores this issue and calls for the pharmaceutical industry to change its approach.
Blue Latitude Health
Engaging physicians during COVID-19
COVID-19 has drastically changed the lives of healthcare professionals. They are emotionally and physically drained and under huge amounts of pressure. They also need pharma’s help. Senior Consultant Pany Koizi outlines five principles for engaging with physicians during the pandemic.
Blue Latitude Health
Fishawack Health adds market access and commercial strategy consultancy Skysis as part of its bold growth plans
Fishawack Health, the global healthcare communications agency, announces the acquisition of Skysis, a boutique consulting firm providing integrated market access and commercial strategy solutions based in the US.
Blue Latitude Health